Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
CA 2477953 A1 · Owner: Roger Williams Hospital · Inventors: Frackelton, Raymond A.; Davol, Pamela A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides methods for determining whether a breast prostate or , ovarian tumor or tumor cell is aggressive based on the quantitative , measurement of p66-Shc and phosphorylated Shc. This invention also provides related methods of 'determining the likelihood of tumor recurrence. This invention further provides a method for determining whether a tumor can be successfully treated using a tyrosine kinase inhibitor. Finally this , invention provides antibodies and kits for practicing the instant methods.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 28, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 28, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 28, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.